A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer-Reference-Cited by-同舟云学术

A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer

Published:2016-01 Issue:2 Volume:155 Page:295-302
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Blum Joanne L.,Gonçalves Anthony,Efrat Noa,Debled Marc,Conte Pierfranco,Richards Paul D.,Richards Donald,Lardelli Pilar,Nieto Antonio,Cullell-Young Martin,Delaloge Suzette

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3675-x.pdf

Reference38 articles.

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752. doi: 10.1038/35021093

2. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. doi: 10.1073/pnas.191367098

3. Aristei C, Leonardi C, Stracci F, Palumbo I, Luini A, Viale G, Cristallini EG, Cavaliere A, Orecchia R (2011) Risk factors for relapse after conservative treatment in T1–T2 breast cancer with one to three positive axillary nodes: results of an observational study. Ann Oncol 22(4):842–847. doi: 10.1093/annonc/mdq470

4. Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, Symmans WF, Pusztai L, Bloom KJ (2003) The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 8(4):307–325

5. Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P (2015) Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat 150(3):621–629. doi: 10.1007/s10549-015-3341-3

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15

2. Tratamento do câncer de mama triplo negativo e impacto na sobrevida das pacientes;Onco.News;2022-11-09

3. Trabectedin ( ET ‐743) in prostate cancer: Endoplasmic reticulum stress‐induced apoptotic effect;Andrologia;2022-09-27

4. Trabectedin in Cancers: Mechanisms and Clinical Applications;Current Pharmaceutical Design;2022-07

5. Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature;Frontiers in Oncology;2021-11-18